Food and Drug Administration this week added dexamethasone sodium phosphate to its lists for temporary compounding by outsourcing facilities and pharmacy compounders during the COVID-19 emergency. Drugs on these lists are intended to address shortages and increase access in the treatment of COVID-19 patients. FDA also this week announced voluntary recalls of two hand sanitizers due to the potential presence of methanol, also known as wood alcohol. Both AAA Cosmética, S.A. de C.V. and 4e Brands North America said they have not received complaints about the products.

Related News Articles

Headline
The AHA’s American Organization of Nursing Leadership affiliate, the American Nurses Association, and Johnson & Johnson this week released a report…
Headline
Pfizer Inc. today announced that the federal government has agreed to purchase an additional 200 million doses of its COVID-19 vaccine. The deal raises the…
Headline
The Health Resources and Services Administration yesterday awarded rural health clinics about $49,500 each for outreach to increase COVID-19 vaccinations in…
Perspective
The widespread belief that we have completely turned the corner in our fight against COVID-19 does not apply equally to all parts of the country. In many…
Headline
Throughout the COVID-19 pandemic, Sutter Health in Northern California used the range of its system to meet the needs of patients, staff and clinicians, from…
Headline
U.S. life expectancy fell by an average of 1.5 years in 2020 to 77.3 years, primarily due to COVID-19, the Centers for Disease Control and Prevention reported…